Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

NCT03097588 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm

Interventions

DRUG: Netupitant
DRUG: Palonosetron Hydrochloride
OTHER: Questionnaire Administration

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]